CA-GUESS?
27.7.2022 17:02:14 CEST | Business Wire | Press release
In collaboration with Homeboy Industries, GUESS has developed a unique process to give new life to old clothing. By transforming recycled pieces into fun, fashionable creations, GUESS is building a new pathway to being fabulously sustainable. Sustainability is at the heart of all that GUESS does, and the Company’s partnership with the non‐profit Homeboy Industries represents this commitment.
GUESS will work directly with Homeboy Recycling, a social enterprise branch of Homeboy Industries on the new Upcycled Collection. In partnering with GUESS, Homeboy Recycling has expanded from exclusively electronics recycling into the world of textiles and apparel. GUESS and Homeboy Recycling have created not only a remarkable new line of goods and apparel, but a new way to support environmental sustainability, facilitate creativity, create new jobs, and uplift our community: upcycled with a whole lot of heart.
It is with absolute pride that GUESS announces the Upcycled Collection. A collection unlike any other, because no two pieces are alike. Transforming recycled clothing yields distinctly unique pieces, and that is its ultimate appeal. Tote bags, patchwork denim, bustiers, and even throw pillows; upcycled fashion for everyone. The Upcycled Collection is a sustainable, fashionable, purposeful way to shop‐the truest form of circular fashion.
“Homeboy Industries is grateful for the partnership with GUESS for the Upcycled Collection. We thank GUESS for supporting our mission to provide hope, training, and support to this marginalized population, allowing them to change the arc of their lives and become contributing members of the community. Homeboy Industries provides comprehensive trauma‐informed, wrap‐around support services such as tattoo removal, mental health services, education, legal, housing navigation, case management, workforce development, and job training,” says Chris Zwicke, CEO of Homeboy Industries. “Through this partnership, our employees at our fastest growing social enterprise, Homeboy Recycling, will gain more job skills and training, which we are very excited about.”
“The Upcycled Collection in collaboration with Homeboy Industries is designed with the hope that each piece can give purpose to a member of the community who can learn the skills needed to turn discarded merchandise into desirable, commodified items with an eye to the fashion set. The designs are determined by the resources at hand, which are carefully organized and sorted. The product range is fashion to non‐fashion pieces, so there is something for everyone. And the true joy is the wonderment around the former life of each piece and how it came to be,” says Amy Enuke, Young Contemporary Design Director.
With GUESS’ commitment to circular fashion and Homeboy Recycling’s foundation of sustainability, this partnership is the launching pad for a new kind of sustainable fashion—one that not only supports the environment but also directly supports our communities. To learn more about GUESS’ commitment to our planet, visit guess.com/sustainability
About GUESS?, Inc.
Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand. Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. As of April 30, 2022, the Company directly operated 1,073 retail stores in the Americas, Europe and Asia. The Company’s partners and distributors operated 565 additional retail stores worldwide. As of April 30, 2022, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com.
About Homeboy Recycling
Homeboy Recycling is a certified and award-winning social enterprise offering nationwide services for the proper disposal and management of IT assets. As one of the few R2 (Responsible Recycling) and B Corp certified companies in the world, Homeboy is committed to the highest possible standards for electronics reuse, e-waste recycling and the destruction of sensitive data. Each year, Homeboy refurbishes thousands of computers and diverts millions of pounds of electronics away from the landfill while creating jobs for people facing systemic barriers to employment. Beyond our IT asset disposition and e-waste services, we see ourselves broadly as a partner in the circular economy. We work with committed manufacturers and brands to develop socially and environmentally beneficial solutions for their products after their first life. In this capacity, we are expanding our services to include apparel/textiles and other products/materials that fit our mission.
As part of Homeboy Industries, the world’s preeminent gang rehabilitation and re-entry program, Homeboy Recycling proudly employs people committed to transforming their lives after incarceration. For more information, visit https://homeboyrecycling.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005664/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom